论文信息 - Phase I, first-in-human trial of Bruton’s tyrosine kinase inhibitor M7583 in patients with B-cell malignancies - 字舞流文

Phase I, first-in-human trial of Bruton’s tyrosine kinase inhibitor M7583 in patients with B-cell malignancies

J. Gribben | P. Zinzani | S. Rule | W. Jurczak | J. Scheele | M. Długosz-Danecka | W. Townsend | B. Sarholz | M. Dyroff | D. Tucker